Effects of buspirone on an animal model of tardive dyskinesia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 8, 1999, Pages 1405-1418

  Queiroz, Claudio M T ^a   Frussa Filho, Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Buspirone; Dopamine; Orofacial movements; Rat; Reserpine; Serotonin; Tardive dyskinesia

Indexed keywords

APOMORPHINE; BUSPIRONE; DOPAMINE AUTORECEPTOR; RESERPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOPAMINERGIC ACTIVITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INVOLUNTARY MOVEMENT; MALE; MASTICATION; MUSCLE TWITCH; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TARDIVE DYSKINESIA; YAWNING;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BUSPIRONE; DISEASE MODELS, ANIMAL; DOPAMINE; DYSKINESIA, DRUG-INDUCED; FACE; MALE; MASTICATION; MOTOR ACTIVITY; RATS; RATS, WISTAR; RESERPINE; SEROTONIN AGONISTS; TONGUE;

EID: 0033231303     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00074-3     Document Type: Article

References (66)

1. Baldessarini, R.J. and Tarsy, D. (1979) Relationship of the actions of neuroleptic drugs to the patophysiology of tardive dyskinesia. Int. Rev. Neurol. 21: 1-45.
2. Baskin, P. and Salamone, J.D. (1993). Vacuous jaw movements in rats induced by acute reserpine administration: Interactions with diffecnt doses of apomorphine. Pharmacol. Biochem. Behav. 46(4): 793-797.
3. Bergamo, M.; Abilio, V.C.; Queiroz, C.M.T.; Barbosa-Júnior, H.N.; Abdanur L.R.A. and Frussa-Filho, R. (1997). Effects of age on a new model of tardive dyskinesia. Neurobiol. Aging. 18(6): 623-629.
4. Bernardi, M.M; De Sousa, H. and Palermo-Neto J. (1981) Effect of single and long-term haloperidol administration on open-field behavior of rats. Psycopharmacol. 73: 171-175.
5. Burt, D.R.; Creese, I. and Snyder, S.H. (1977) Anti-schizophrenic drugs - chronic treatment elevates DA receptor binding in the brain. Science 196: 326-327.
6. Casey, D.E. (1985) Tardive dyskinesia reversible and irreversible. In: Dyskinesia: Research and Treatment, D.E.Casey, T.N.Chase, A.V.Christensen and J.Gerlach (Eds.), pp 88-98, Springer-Verlag, Berlim.
7. Casey, D.E. (1995) Tardive dyskinesia - Patophysiology. In: Psychopharmacology: The Fourth Generation of Progress, F.E.Bloom and D.J.Kupfer (Eds), pp 1497-1502, Raven Press, New York.
8. Cimino, M.; Ponzio, F.; Achilli, C.; Vantini, G.; Perego, C.; Algeri, S. and Garattini, S. (1983) Dopaminergic effects of buspirone, a novel anxiolytic agent. Biochem. Pharmacol. 32: 1069-1074.
9. Conceição, I.M. and Frussa-Filho, R. (1993) Effects of single administration of buspirone on catalepsy, yawning and stereotypy in rats. Brazilian J. Med. Biol. Res. 26: 71-74.
10. Eberle-Wang, K.; Lucki, I. and Chesselet, M.F. (1996) A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia. Neurosci 172: 117-128.
11. Enkelmann, R. (1991) Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder Psychopharmacol. 105: 428-432.
12. Ernst, A.M. (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacol. 10: 316-324.
13. Felicio, L.F.; Nasello, A.G. and Palermo-Neto, J. (1987) Dopaminergic supersensitivity after long-term bromopride treatment. Physiol. and Behav. 41: 433-437.
14. Frussa-Filho, R. and Palermo-Neto, J. (1988) Effects of single and long-term metoclopramide administration on open-field and stereotyped behavior of rats. Europ. J. Pharmacol. 149: 323-329.
15. Frussa-Filho, R. and Palermo-Neto, J. (1990) Effects of single and long-term sulpiride administration on open-field and stereotyped behavior of rats. Brazilian J. Med. Biol. Res. 23 463-472.
16. Frussa-Filho, R. and Palermo-Neto, J. (1991) Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats. Physiol. and Behav. 50: 825-830.
17. Frussa-Filho, R.; Abílio, V.C.; Bergamo, M. and Palermo-Neto, J. (1997) Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats. J. Pharm. Pharmacol. 49(4) 412-415.
18. Gamble, S.J. and Waddington, J.L. (1981) Multiplicity of dopamine-mediated behaviours during six months phenotiazine neuroleptic treatment in young but not aged rats. Br. J. Pharmacol. 74: 225.
19. Garattini, S.; Caccia, S. and Mennini, T. (1982) Notes on buspirone's mechanism of action. J. Clin. Psychiat. 43: 19-22.
20. Gerlach, J. (1985) Patophysiological mechanisms underlying tardive dyskinesia. In: Dyskinesia: Research and treatment, D.E.Casey, T.N.Chase, A.V.Christensen, J.Gerlach (Eds), pp 99-104, Springer-Verlag, Berlim.
21. Gerlach, J. and Casey, D.E. (1988) Tardive dyskinesia. Acta Psychiatry Scan. 77: 369.
22. Higgins, G.A.; Bradbury, A.J.; Jones, B.J. and Oakley, N.R. (1988) Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors iin the dorsal raphe nucleus of the rat. Neuropharmacol. 27: 993-1001.
23. Hillegaart, V.; Hjorth, S. and Ahlenius, S. (1990) Effects of 5-HT and 8-OHDPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. 81: 131-145.
24. Hjorth, S. and Magnusson, T. (1988) The 5-HT1A receptor agonist, 8OHDPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. N.-sch. Arch. Pharmacol. 338: 463-471.
25. Hutson, P.H.; Sarna, G.S.; O'Connell, M.T. and Curzon, G. (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100: 276-280.
26. Johnson, N. and Leone, F. (1974) Statistics and experimental design. In: Engineering and physical sciences, J.Wiley (Ed), New York.
27. Kane, J.M. (1995) Tardive dyskinesia: Epidemiological and clinical presentation. In: Psychopharmacology: The Fourth Generation of Progress, F.E.Bloom and D.J.Kupfer (Eds), pp 1485-1495, Raven Press, New York.
28. Kane, J.M.; Woerner, M. and Lieberman, J. (1985) Tardive dyskinesia: prevalence, incidence and risk factors. In: Dyskinesia: Research and Treatment, D.E.Casey, T.N.Chase, A.V.Christensen, J.Gerlach (Eds), pp 72-78, Springer-Verlag, Berlim.
29. Kapur, S. and Remington, G. (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153: 466-476.
30. Klawans, H.L. (1973) The pharmacology of tardive dyskinesia. Am. J. Psychol. 130: 82-86.
31. Liminga, U.; Johnson, A.E.; Andrén, P.E. and Gunne, LM. (1993) Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat. Pharmacol Biochem and Behav 46: 427-433.
32. McMillen, B. A. (1985) Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. J. Neural Transm. 64: 1-12.
33. McMillen, B.A.; Matthews, R.T.; Sanghera, M.K.; Shepard, P.D. and German, D.C. (1983) Dopamine receptor antagonismby the novel anti-anxiety drug, buspirone. J. Neurosci. 3 733-738.
34. Mennini, T.; Gobbi, M.; Ponzio, F. and Garattini, S. (1986) Neurochemical effects of buspirone in rat hippocampus: evidence for selective activation of 5-HT neurones .Arch. Int. Pharmacodyn. Ther. 279: 40-49.
35. Misra, C.H. Shelat, H. and Smith, R.C. (1982) Age affects dopamine receptors changes during chronic administration of fluphenazine. Eur. J. Pharmacol. 85: 343-346.
36. Moss, L.E.; Neppe, V.M. and Drevets, W.C. (1993) Buspirone in the treatment of tardive dyskinesia. J. Clin. Psychopharmacol. 13: 204-209.
37. Neisewander, J.L., Castañeda, E. and Davis, D.A.; (1994) Dose-dependent differences in the development of reserpine-induced oral-dyskinesia in rats: support for a model of tardive dyskinesia. Psychopharmacol. 116: 79-84.
38. Neisewander, J.L.; Castañeda, E., Davis, D.A.; Elson, H.J. and Sussman, A.N. (1996) Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia. Eur. J. Pharmacol. 305: 13-21.
39. Neisewander, J.L.; Lucki, I. and McGonigle, P. (1991a) Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res. 558: 27-35.
40. Neisewander, J.L.; Lucki, I. and McGonigle, P. (1991b) Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. J. Pharmacol. Exp. Ther. 257; 850-860.
41. Neppe, V.M. (1989) High-dose buspirone in case. Lancet 2: 8677.
42. rd Annual Meeting of the American Psychiatry Association, New York.
43. Peroutka, S. (1985). Selective interaction of novel anxyolitic with 5-hydrosytriptamine 1A receptor. Biol. Psychiatr. 20: 971-979.
44. Price, M.T.; Fibiger, H.C. (1974) Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. Eur. J. Pharmacol. 29(2) 249-252.
45. Queiroz, C.M.T. and Frussa-Filho, R. (1997) Effects of buspirone on dopaminergic supersensitivity. Life Sci. 61(4): 371-382.
46. Randall, P.K. Severson, J.A. and Finch, C.E. (1981) Aging and the regulation of striatal dopaminergic mechanisms in mice. J. Pharmacol. Exp. Ther. 219: 695-700.
47. Seeman, P. (1980) Brain dopamine receptors. Pharmacol. Rev. 32: 229-313.
48. Shonecker, M. (1957) Ein eigentumliches syndrom in earlen Bereich bei. Megaphen Applikation Nervenartz 28: 34.
49. Siegel, S. (1956) Non-parametric statistic for the behavioral sciences, pp 117-127, McGraw-Hill, New York.
50. Sinton, C.M. and Fallon, S.C. (1988) Electrophysiological evidence for a functional diferentiation between subtypes of the 5-HT1 receptor. Eur. J. Pharmacol. 157: 173-181.
51. Sprouse, U.S. and Aghajanian, G.K. (1987) Electrophysiological responses of serotonergic dorsal raphe neurones to 5-HT1A and 5-HT1B agonists. Synapse 1: 3-9.
52. Steinpreis, R.E. and Salamone, J.D. (1993) Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol. Biochem. Behav. 46(2): 405-409.
53. Stewart, B.R.; Jenner, P. and Marsden, C.D. (1989) Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs. Eur J Pharmacol. 162: 101-107.
54. Stoessl, A.J.; Dourish, C.T. and Ivesen, S.D. (1987) Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra. Psychopharmacol. 93: 336-342.
55. Tunnicliff, G.; Brokaw, J.J.; Hausz, J.A.; Matheson, G.K. and White, G.W. (1992) Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis. Neuropharmacol. 31(10): 991-995.
56. Uhrbrand, L. and Faurbye, A. (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia 1 408-418.
57. Verge, D.; Daval, G.; Patey, A.; Gozlan, H.; El Mestikawy, S. and Hamon, M. (1985) Presynaptic 5-HT autoreceptors on serotoninergic cell bodies and/or dendrites but not terminals are of 5HT1A subtype. Eur. J. Pharmacol. 113: 463-462.
58. Vital, M.A.B.F.; Flório, J.C.; Frussa-Filho, R.; De Lucia, R.; Tufik, S. and Palermo-Neto, J. (1998) Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Life Sci. 62(13): 1161-1169.
59. Vital, M.A.B.F.; Frussa-Filho, R. and Palermo-Neto J. (1995) Effects of monosialoganglioside on dopaminergic supersensitivity. Life Sci. 56: 2299-2307.
60. Vital, M.A.B.F.; Frussa-Filho, R. and Palermo-Neto, J. (1997) Effects of monosialoganglioside on a new model of tardive dyskinesia. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 21: 1169-1179.
61. Waddington, J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacol. 101: 431-447.
62. Waddington, J.L and Gamble, S.J. (1980) Defferential effects of ageing on distinct features of apomorphine stereotypy in the adult rat. Neurosci. Lett. 20: 95-99.
63. Weissmann-Nanopoulos, D.; Mach, E.; Magre, J.E.; Demassy, Y. and Pujol, J.F. (1985) Evidence for the localisation of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7: 1061-1072).
64. Wolfarth, S. and Ossowska, K. (1989) Can supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia? Prog. Neuropsychopharmacol. Biol. Psychiat. 13: 789-840.
65. Yoshimoto, K. and McBride, W.J. (1992) Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat. Neurochem. Res. 17(5): 401-407.
66. Inquires and reprint requests should be adressed to: Roberto Frussa Filho Rua Botucatu, 862 - Ed. J. Leal Prado CEP 04023-062 São Paulo, SP, Brasil email frussa.farm@epm.br fax (55-11) 273 1766